Kits Eyecare Ltd.
KTYCF
$9.76
$0.050.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.23% | 24.80% | 28.79% | 31.08% | 29.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.23% | 24.80% | 28.79% | 31.08% | 29.80% |
| Cost of Revenue | 21.35% | 21.11% | 23.41% | 26.86% | 27.42% |
| Gross Profit | 32.51% | 32.07% | 39.65% | 39.48% | 34.51% |
| SG&A Expenses | 30.55% | 24.48% | 26.81% | 26.96% | 22.76% |
| Depreciation & Amortization | -10.60% | -31.20% | -39.98% | -51.82% | -58.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.13% | 21.79% | 23.86% | 25.86% | 24.54% |
| Operating Income | 57.47% | 198.90% | 1,287.80% | 1,998.76% | 661.18% |
| Income Before Tax | -13.32% | 12.53% | 25,669.47% | 1,563.35% | 522.86% |
| Income Tax Expenses | 10.94% | 43.98% | 1,701.27% | 2,089.31% | 606.38% |
| Earnings from Continuing Operations | -23.87% | -1.00% | 5,073.72% | 1,370.47% | 494.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.87% | -1.00% | 5,073.72% | 1,370.47% | 494.65% |
| EBIT | 57.47% | 198.90% | 1,287.80% | 1,998.76% | 661.18% |
| EBITDA | 38.36% | 102.34% | 254.53% | 320.50% | 371.70% |
| EPS Basic | -26.94% | -2.26% | 4,907.69% | 1,378.95% | 490.64% |
| Normalized Basic EPS | 0.21% | 35.76% | 28,500.00% | 1,551.02% | 519.28% |
| EPS Diluted | -23.15% | 4.73% | 2,060.66% | 5,360.00% | 377.81% |
| Normalized Diluted EPS | 2.86% | 37.01% | 35,700.00% | 1,830.77% | 482.10% |
| Average Basic Shares Outstanding | 2.82% | 1.70% | 1.34% | 1.02% | 0.65% |
| Average Diluted Shares Outstanding | -0.95% | -0.85% | 1.07% | 1.34% | 4.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |